54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 08
12:54 UTC
|
DGICA
Donegal Group
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $18.00→ $20.00+11.1% |
|
Jul 08
12:54 UTC
|
CHTR
Charter Communications
|
◎ Target | Kannan Venkateshwar ★★☆☆☆ #2407 | Underweight | $200.00→ $130.00-35.0% |
|
Jul 08
12:54 UTC
|
CCEP
Coca-Cola Europacific Partners
|
◎ Target | Chris Carey not yet tracked | Overweight | $110.00→ $115.00+4.5% |
|
Jul 08
12:54 UTC
|
CB
Chubb
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Outperform | $374.00→ $389.00+4.0% |
|
Jul 08
12:54 UTC
|
CAG
Conagra Brands
|
◎ Target | Andrew Lazar ★★★☆☆ #2156 | Overweight | $18.00→ $16.00-11.1% |
|
Jul 08
12:54 UTC
|
BWIN
Baldwin Insurance Group
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Outperform | $26.00→ $31.00+19.2% |
|
Jul 08
12:54 UTC
|
BVN
Buenaventura Mining
|
◎ Target | Carlos De Alba ★★☆☆☆ #2310 | Overweight | $42.50→ $34.50-18.8% |
|
Jul 08
12:54 UTC
|
BSX
Boston Scientific
|
◎ Target | Mike Matson not yet tracked | Buy | $77.00→ $57.00-26.0% |
|
Jul 08
12:54 UTC
|
BRO
Brown & Brown
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $72.00→ $74.00+2.8% |
|
Jul 08
12:54 UTC
|
BOW
Bowhead Specialty
|
◎ Target | Meyer Sheilds not yet tracked | Outperform | $34.00→ $36.00+5.9% |
|
Jul 08
12:54 UTC
|
BKR
Baker Hughes
|
◎ Target | Charles Minervino ★★★☆☆ #1206 | Positive | $80.00→ $70.00-12.5% |
|
Jul 08
12:54 UTC
|
AXS
Axis Capital
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Outperform | $126.00→ $131.00+4.0% |
|
Jul 08
12:54 UTC
|
ATLC
Atlanticus
|
◎ Target | John Hecht ★★★☆☆ #1892 | Buy | $100.00→ $115.00+15.0% |
|
Jul 08
12:54 UTC
|
AON
AON
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Outperform | $404.00→ $400.00-1.0% |
|
Jul 08
12:54 UTC
|
ALLY
Ally Financial
|
◎ Target | Brandon Berman ★★★☆☆ #978 | Buy | $52.00→ $53.00+1.9% |
|
Jul 08
12:54 UTC
|
ALL
Allstate
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $242.00→ $255.00+5.4% |
|
Jul 08
12:54 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $242.00→ $261.00+7.9% |
|
Jul 08
12:54 UTC
|
AIZ
Assurant
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $270.00→ $310.00+14.8% |
|
Jul 08
12:54 UTC
|
AIG
American International Group
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Outperform | $98.00→ $95.00-3.1% |
|
Jul 08
12:54 UTC
|
AFG
American Financial Group
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $140.00→ $148.00+5.7% |
|
Jul 08
12:54 UTC
|
ACGL
Arch Capital Group
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $102.00→ $99.00-2.9% |
|
Jul 08
12:54 UTC
|
UHS
Universal Health Services
|
↓ Downgrade | Andrew Mok not yet tracked | Overweight→ Negative | |
|
Jul 08
12:54 UTC
|
HCA
HCA Healthcare
|
↓ Downgrade | Andrew Mok not yet tracked | Overweight→ Negative | |
|
Jul 08
12:54 UTC
|
GLOB
Globant
|
↓ Downgrade | Maria Clara Infantozzi not yet tracked | Outperform→ Market Perform | $39.00 |
|
Jul 08
12:54 UTC
|
CYH
Community Health Systems
|
↓ Downgrade | Andrew Mok not yet tracked | Equal Weight→ Underweight | $3.00 |
|
Jul 08
12:54 UTC
|
BBWI
Bath & Body Works
|
↓ Downgrade | Kate McShane ★★☆☆☆ #2411 | Neutral→ Sell | $23.00→ $19.00-17.4% |
|
Jul 08
12:54 UTC
|
UGP
Ultrapar Participacoes
|
↑ Upgrade | Leonardo Marcondes ★★☆☆☆ #2762 | Neutral→ Buy | $6.80→ $7.40+8.8% |
|
Jul 08
12:54 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | firm only | Outperform | $10.00 |
|
Jul 08
12:54 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | Ryan Deschner ★★★★☆ #658 | Market Perform→ Outperform | $10.00 |
|
Jul 08
12:54 UTC
|
SBRA
Sabra Healthcare REIT
|
↑ Upgrade | Michael Lewis ★★★☆☆ #1214 | Hold→ Buy | $22.00 |
|
Jul 08
12:54 UTC
|
RH
RH
|
↑ Upgrade | Kate McShane ★★☆☆☆ #2411 | Neutral | $86.00→ $155.00+80.2% |
|
Jul 08
12:54 UTC
|
PRG
PROG
|
↑ Upgrade | John Hecht ★★★☆☆ #1892 | Hold→ Buy | $33.00→ $60.00+81.8% |
|
Jul 08
12:54 UTC
|
ODFL
Old Dominion Freight Line
|
↑ Upgrade | Christian Wetherbee ★☆☆☆☆ #2969 | Underweight→ Overweight | $250.00 |
|
Jul 08
12:54 UTC
|
DLTR
Dollar Tree
|
↑ Upgrade | Bobby Griffin ★★★★☆ #401 | Market Perform→ Outperform | $140.00 |
|
Jul 08
11:21 UTC
|
BBWI
Bath & Body Works
|
↓ Downgrade | Kate McShane ★★☆☆☆ #2411 | Neutral→ Sell | |
|
Jul 08
11:21 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | firm only | Outperform | |
|
Jul 08
11:21 UTC
|
RH
RH
|
↑ Upgrade | Kate McShane ★★☆☆☆ #2411 | Neutral | |
|
Jul 08
11:21 UTC
|
PRG
PROG
|
↑ Upgrade | John Hecht ★★★☆☆ #1892 | Hold→ Buy | |
|
Jul 08
11:21 UTC
|
ODFL
Old Dominion Freight Line
|
↑ Upgrade | Christian Wetherbee ★☆☆☆☆ #2969 | Underweight→ Overweight | |
|
Jul 08
11:21 UTC
|
IVPAF
Ivanhoe Mines
|
↑ Upgrade | firm only | Negative→ Overweight | |
|
Jul 08
11:21 UTC
|
DLTR
Dollar Tree
|
↑ Upgrade | firm only | Outperform | $140.00 |
|
Jul 08
10:21 UTC
|
DLTR
Dollar Tree
|
↑ Upgrade | firm only | Outperform | |
|
Jul 08
10:21 UTC
|
ALGT
Allegiant Travel
|
↑ Upgrade | Atul Maheswari ★★☆☆☆ #2740 | Neutral→ Buy | |
|
Jul 08
09:21 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
↓ Downgrade | firm only | Overweight | |
|
Jul 08
05:20 UTC
|
GLOB
Globant
|
↓ Downgrade | firm only | Market Perform | |
|
Jul 08
01:20 UTC
|
COMP
Compass
|
◎ Target | Alec Brondolo ★★☆☆☆ #2333 | Equal Weight | $9.00→ $12.00+33.3% |
|
Jul 08
00:20 UTC
|
ZYME
Zymeworks
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Buy | $28.00→ $31.00+10.7% |
|
Jul 08
00:20 UTC
|
ZG
Zillow Group
|
◎ Target | Alec Brondolo ★★☆☆☆ #2333 | Equal Weight | $45.00→ $46.00+2.2% |
|
Jul 08
00:20 UTC
|
XPO
XPO
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1358 | Buy | $236.00→ $257.00+8.9% |
|
Jul 08
00:20 UTC
|
XNCR
Xencor
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Buy | $29.00→ $27.00-6.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.